Efficacy of a hepatitis C virus core antigen enzyme-linked immunosorbent assay for the identification of 'window-phase' blood donations

Vox Sanguinis
S R LeeG Green

Abstract

Recent studies have suggested that potentially infectious donations provided during the antibody-negative 'window' phase of hepatitis C virus (HCV) infection may be identified by testing for viral RNA or HCV core protein. We therefore evaluated the performance of an HCV antigen enzyme-linked immunosorbent assay (ELISA) for identification of window-phase donations and for prospective screening of blood donors. One-hundred and twenty-eight archived plasma donations containing HCV RNA, but lacking antibody to HCV (anti-HCV), were tested by using the HCV antigen ELISA, together with 9951 freshly collected serum and plasma specimens from blood donors. HCV core antigen was detected in 94% (120/128) of window-phase plasma donations. Overall specificity in freshly collected blood donor specimens was 99.74%. Two putative window-phase donations containing HCV core protein and viral RNA were identified from paid plasma donors by prospective testing with the HCV antigen ELISA. These results indicate that an HCV antigen ELISA can identify almost all (94%) of viraemic donations given during the seronegative window phase of infection. The performance of the HCV antigen ELISA appears to be suitable for large-scale screening of blood donations.

References

Jun 27, 1996·The New England Journal of Medicine·G B SchreiberJ J Korelitz

❮ Previous
Next ❯

Citations

Mar 18, 2005·European Journal of Clinical Microbiology & Infectious Diseases : Official Publication of the European Society of Clinical Microbiology·M LindhG Norkrans
Dec 7, 2002·Microbes and Infection·Ayaz M Majid, David R Gretch
Sep 11, 2002·Transfusion Medicine·J Barbara, R Eglin
Jul 31, 2002·Transfusion·Bryce LarkeJudith Klein
Oct 19, 2002·Transfusion·C Micha NüblingJohannes Löwer
Jun 27, 2002·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·Magali Bouvier-AliasJean-Michel Pawlotsky
Oct 31, 2002·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·Jean-Michel Pawlotsky
Jun 13, 2001·Tumori·J A Barbara
Sep 10, 2011·Journal of Biomedicine & Biotechnology·Chen-Ji HuangChih-Yu Cheng
Jan 1, 2010·The Libyan Journal of Medicine·Abdulatif KhmmajAmna Rayani
Apr 14, 2015·Journal of Clinical Virology : the Official Publication of the Pan American Society for Clinical Virology·Tonya Mixson-HaydenSaleem Kamili
Mar 12, 2003·Journal of Medical Virology·Alessandro R ZanettiCharles Tackney
Jul 1, 2004·Transfusion·Magdalena LetowskaAleksandra Rosiek
Feb 13, 2003·Scandinavian Journal of Caring Sciences·Torill Christine Lindstrøm, Anne Røsvik
Jan 18, 2005·Journal of Clinical Virology : the Official Publication of the Pan American Society for Clinical Virology·Katja SemeAdriana Vince
May 23, 2017·Journal of the International AIDS Society·Léa DuchesneKarine Lacombe
Apr 28, 2018·Clinical Chemistry and Laboratory Medicine : CCLM·Claudio GalliMario Plebani

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.